The University of Chicago Header Logo

Connection

Harvey M. Golomb to Recombinant Proteins

Back to Details
This is a "connection" page, showing publications Harvey M. Golomb has written about Recombinant Proteins.
Harvey M. Golomb
Connection Strength
0.434
Recombinant Proteins
  1. Interferon-induced surface alterations in hairy cells. A review. Scanning Microsc. 1988 Mar; 2(1):485-92.
    View in: PubMed
    Score: 0.065
  2. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol. 1995 Apr; 13(4):974-82.
    View in: PubMed
    Score: 0.026
  3. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
    View in: PubMed
    Score: 0.026
  4. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515. Leukemia. 1994 Dec; 8(12):2037-40.
    View in: PubMed
    Score: 0.026
  5. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma. 1994; 14 Suppl 1:89-93.
    View in: PubMed
    Score: 0.024
  6. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol. 1993 Mar; 83(3):519-20.
    View in: PubMed
    Score: 0.023
  7. Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986. Leukemia. 1992 Nov; 6(11):1177-80.
    View in: PubMed
    Score: 0.022
  8. Duration of response after interferon treatment of hairy cell leukemia. Blood. 1990 Jun 15; 75(12):2465-7.
    View in: PubMed
    Score: 0.019
  9. Hairy cell leukemia. Current management. Hematol Oncol Clin North Am. 1990 Apr; 4(2):489-502.
    View in: PubMed
    Score: 0.019
  10. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
    View in: PubMed
    Score: 0.018
  11. Is there a direct differentiation-inducing effect of human recombinant interferon on hairy cell leukemia in vitro? Cancer. 1989 Jul 15; 64(2):374-8.
    View in: PubMed
    Score: 0.018
  12. What is the choice of treatment for hairy cell leukemia? J Clin Oncol. 1989 Feb; 7(2):156-8.
    View in: PubMed
    Score: 0.017
  13. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b. Semin Oncol. 1988 Oct; 15(5 Suppl 5):7-9.
    View in: PubMed
    Score: 0.017
  14. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia. J Natl Cancer Inst. 1988 May 04; 80(5):369-73.
    View in: PubMed
    Score: 0.016
  15. In vivo induction of proteins during therapy of hairy cell leukemia with alpha-interferon. Blood. 1987 Jun; 69(6):1570-3.
    View in: PubMed
    Score: 0.015
  16. The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
    View in: PubMed
    Score: 0.015
  17. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000 Nov 01; 96(9):2981-6.
    View in: PubMed
    Score: 0.010
  18. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.
    View in: PubMed
    Score: 0.008
  19. Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):38-41.
    View in: PubMed
    Score: 0.007
  20. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. Leukemia. 1995 Jul; 9(7):1116-20.
    View in: PubMed
    Score: 0.007
  21. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8.
    View in: PubMed
    Score: 0.006
  22. Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6.
    View in: PubMed
    Score: 0.006
  23. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
    View in: PubMed
    Score: 0.004
  24. Heat shock proteins in normal and leukemic blood cells. J Interferon Res. 1989 Apr; 9(2):195-204.
    View in: PubMed
    Score: 0.004
  25. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
    View in: PubMed
    Score: 0.004
  26. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3.
    View in: PubMed
    Score: 0.004
  27. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
    View in: PubMed
    Score: 0.004
  28. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.